Monte Rosa Therapeutics (GLUE)
(Delayed Data from NSDQ)
$5.32 USD
-0.29 (-5.17%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $5.33 +0.01 (0.19%) 7:38 PM ET
2-Buy of 5 2
F Value A Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.56 |
EPS Last Quarter | -0.58 |
Last EPS Surprise | -1.75% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.25 |
Next Year | -2.17 |
EPS (TTM) | -2.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.29M | 4.29M | 17.22M | 17.22M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 4.40M | 4.40M | 17.77M | 17.77M |
Low Estimate | 4.17M | 4.17M | 16.67M | 16.67M |
Year ago Sales | 0.00M | 0.00M | NA | 17.22M |
Year over Year Growth Est. | NA | NA | NA | 0.00% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.56 | -0.59 | -2.25 | -2.17 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.55 | -0.57 | -2.19 | -2.04 |
High Estimate | -0.51 | -0.52 | -1.88 | -1.43 |
Low Estimate | -0.64 | -0.66 | -2.51 | -3.01 |
Year ago EPS | -0.65 | -0.71 | -2.63 | -2.25 |
Year over Year Growth Est. | 13.85% | 16.90% | 14.45% | 3.78% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.56 | -0.59 | -2.25 | -2.17 |
7 Days Ago | -0.56 | -0.59 | -2.25 | -2.17 |
30 Days Ago | -0.56 | -0.59 | -2.25 | -2.17 |
60 Days Ago | -0.63 | -0.67 | -2.55 | -2.43 |
90 Days Ago | -0.64 | -0.70 | -2.44 | -2.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.56 | -0.59 | -2.25 | -2.17 |
Zacks Consensus Estimate | -0.56 | -0.59 | -2.25 | -2.17 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.58 | -0.70 | -0.71 | -0.65 | NA |
Estimate | -0.57 | -0.75 | -0.72 | -0.70 | NA |
Difference | -0.01 | 0.05 | 0.01 | 0.05 | 0.03 |
Surprise | -1.75% | 6.67% | 1.39% | 7.14% | 3.36% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more